Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics
- 1 November 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 59 (11) , 1583-1584
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatinJournal of Pharmacy and Pharmacology, 2006
- Preparation and Evaluation of SEDDS and SMEDDS Containing CarvedilolDrug Development and Industrial Pharmacy, 2005
- In vitro investigation on the impact of the surface‐active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolamBiopharmaceutics & Drug Disposition, 2004
- Clinical Pharmacokinetics of AtorvastatinClinical Pharmacokinetics, 2003
- Lipid-based formulations for intestinal lymphatic deliveryEuropean Journal of Pharmaceutical Sciences, 2002
- Microemulsion formulation for enhanced absorption of poorly soluble drugsJournal of Controlled Release, 2002
- Statins: mechanism of action and effectsJournal of Cellular and Molecular Medicine, 2001
- AtorvastatinDrugs, 2001
- How Well Tolerated Are Lipid-Lowering Drugs?Drugs & Aging, 2001
- Uptake of drugs into the intestinal lymphatics after oral administrationAdvanced Drug Delivery Reviews, 1997